Olema Pharmaceuticals
OLMA
195 hedge funds and large institutions have $1.51B invested in Olema Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 73 increasing their positions, 51 reducing their positions, and 50 closing their positions.
272% more call options, than puts
Call options by funds: $41.3M | Put options by funds: $11.1M
43% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 51
8% less first-time investments, than exits
New positions opened: 46 | Existing positions closed: 50
3% less funds holding
Funds holding: 200 → 195 (-5)
15.73% less ownership
Funds ownership: 132.15% → 116.42% (-16%)
33% less capital invested
Capital invested by funds: $2.27B → $1.51B (-$755M)
73% less funds holding in top 10
Funds holding in top 10: 11 → 3 (-8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$119M |
| 2 |
State Street
Boston,
Massachusetts
|
+$45.7M |
| 3 |
SL
Siren LLC
Greenwich,
Connecticut
|
+$32.4M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$25.6M |
| 5 |
DFO
Duquesne Family Office
New York
|
+$22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$28M |
| 2 |
VPC
Vestal Point Capital
New York
|
-$27.2M |
| 3 |
SC
Samlyn Capital
New York
|
-$26.7M |
| 4 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
-$23M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$14.2M |
OLMA Hedge Fund Activity: Q1 2026 in Review
195 of the 8,191 institutional investors tracked by Wall St. Rank reported a position in Olema Pharmaceuticals (OLMA) for Q1 2026, worth a combined $1.51B — down 33% from $2.27B a quarter earlier.
Sellers outnumbered buyers: 50 funds closed out of OLMA and 46 opened new positions — a net loss of 4 holders — while 51 trimmed existing stakes and 73 added.
The largest buyer was Fidelity Investments, adding an estimated $119M. The largest seller was Franklin Resources, cutting an estimated $28M.
- 195 institutional investors held Olema Pharmaceuticals (OLMA) as of Q1 2026, down from 200 in Q4 2025.
- Funds reported $1.51B of Olema Pharmaceuticals stock for Q1 2026, down 33% quarter-over-quarter.
- 46 funds opened new Olema Pharmaceuticals positions in Q1 2026 and 50 closed out, a net change of -4 holders.
- The largest Olema Pharmaceuticals buyer in Q1 2026 was Fidelity Investments, an estimated $119M added.
- The largest Olema Pharmaceuticals seller in Q1 2026 was Franklin Resources, an estimated $28M sold.
Based on aggregated 13F filings for Q1 2026.